153Sm-EDTMP Therapy as a Therapeutic Option in Mixed Skeletal Metastases from Renal Cell Carcinoma with Disease Progression Post 2nd Line Tyrosine Kinase Therapy
本文未提供摘要，请点击“查看全文”查看完整内容。